Implication of microRNAs in drug resistance for designing novel cancer therapy - Wikidata - awgldk - TriplyDB

Implication of microRNAs in drug resistance for designing novel cancer therapy

Implication of microRNAs in drug resistance for designing novel cancer therapy

http://www.wikidata.org/entity/Q33903223

about

Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells Targeting Notch to overcome radiation resistance Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach The complexities of epidemiology and prevention of gastrointestinal cancers Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review Circulating microRNAs in cancer: origin, function and application MicroRNAs as therapeutic targets for lung cancer EGFR-TKI resistance in NSCLC patients: mechanisms and strategies Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression Noninvasive visualization of microRNA-16 in the chemoresistance of gastric cancer using a dual reporter gene imaging system A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in lung cancer.Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs The potential clinical applications and prospects of microRNAs in lung cancer Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.Targeting Notch signaling pathway to overcome drug resistance for cancer therapy Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway.miRNA profiles as a predictor of chemoresponsiveness in Wilms' tumor blastema.The complexities of obesity and diabetes with the development and progression of pancreatic cancer.Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review).A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells A let-7b binding site SNP in the 3'-UTR of the Bcl-xL gene enhances resistance to 5-fluorouracil and doxorubicin in breast cancer cells.MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals.miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1 Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and Chemotherapy Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4.The miR-491-3p/mTORC2/FOXO1 regulatory loop modulates chemo-sensitivity in human tongue cancer.MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2 Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM Clinical Impact of a Novel MicroRNA Chemo-Sensitivity Predictor in Gastrooesophageal Cancer.The two faces of FBW7 in cancer drug resistance.MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.

P2860

Q24628819-6BB90A86-A996-490B-99BB-21D2336D932A Q26741846-EB989BDF-0E98-4252-ACE9-3C8873283193 Q26743378-6DDCBEFA-31C2-4153-8FB6-ABF07DCF82C8 Q26752473-1074FA9B-003F-4309-A9D8-48981F172F35 Q26771701-F6C9AC01-0357-4150-902A-A63E2B2C8B15 Q26849477-266E43E5-DC6E-40AE-96EB-C87C57ED6C42 Q26865429-54D0F482-0145-48E8-93D1-2D66DCB48908 Q27008867-BA680BDC-398C-4230-B2FF-971FE72EB1E4 Q27013716-4ADF77BC-CA6A-4D9C-A47A-3F58337200FF Q28293733-E33B3474-470F-46A3-BB2F-D4B5B1C29702 Q28394310-33AC583A-F1C4-45A7-A179-9FA72570AAAB Q28477384-2A21540B-6840-4CE9-A37E-3807A715E8B5 Q28485384-F30F0593-CFB7-43DF-A4FE-3BE6A0239B6D Q28486245-625738A9-C429-4C62-8D72-3F8BC8BA6C78 Q30361915-9D0D0372-D550-4699-A586-F2FED99B6B02 Q30367369-B7179849-180C-4912-A473-555DF71A48B9 Q33734765-A343A861-2186-4950-95A6-F8ECBAFACD37 Q33850064-3722F05D-06D8-4A4D-9599-B328CF630DFB Q33901567-5D50A5EA-AF25-4BDB-856B-D5E77C8B17AA Q34160439-213A876C-80A0-4689-93BA-5F5D5DBC4989 Q34205088-2CBD91B6-5111-4F38-B2B6-B207A5719F17 Q34208986-BA8DD5E4-E594-43A8-9028-282467D43887 Q34310243-6FA793DE-CE61-404C-995A-F5CC1F022892 Q34418312-2CC449E2-2B3C-459B-B9A9-AEE8966AC4DA Q34545051-DC7B0A9A-B174-4238-8DB0-A94B579C10A6 Q34669361-D469AB2E-B380-44DB-B968-221619F8F278 Q34795591-A32C755B-E9E2-4511-BD7C-210627B190A5 Q34988940-73BD986B-2064-469A-9D97-0B255A0EB13F Q35167875-CD3B84E9-B9B2-4F73-BB18-3D735CB50DCB Q35388050-70C407CB-3435-4DAB-8B08-03CC5528FAB5 Q35494926-36FF520A-3AFB-4464-8A25-FA99695D0D68 Q35647187-A8E2859E-A493-4B2B-B3E5-64AEBD5E25D6 Q35709636-58AC1B04-FB2C-4731-BF4B-242C55E39451 Q35740111-C37F7A39-1F0F-4B66-B76A-F2F01A697D97 Q35832262-746A6281-76B8-4361-A775-9A8D2E5EA685 Q35839941-96E2CAC2-D464-40BA-BB98-B85061385753 Q35925992-1FAD5570-9E24-4D67-9B21-B974DB3B7FCF Q35999467-E8FE77C8-6322-4B23-89BE-19700717EE97 Q36186458-02FADE28-29C9-43B3-BB69-DE01BE3F2CD6 Q36232448-94FAAEBD-29E7-4F58-B77A-E011803E0980

P2860

Implication of microRNAs in drug resistance for designing novel cancer therapy

http://www.wikidata.org/entity/Q33903223

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Implication of microRNAs in drug resistance for designing novel cancer therapy

@ast

Implication of microRNAs in drug resistance for designing novel cancer therapy

@en

type

label

Implication of microRNAs in drug resistance for designing novel cancer therapy

@ast

Implication of microRNAs in drug resistance for designing novel cancer therapy

@en

prefLabel

Implication of microRNAs in drug resistance for designing novel cancer therapy

@ast

Implication of microRNAs in drug resistance for designing novel cancer therapy

@en

P1433

Q33903223-E6390CF3-A783-44DE-B248-8410C44CD37F

P1476

Q33903223-A5ECBAB1-97C0-47B7-8787-C66D3CD3612F

P2093

Q33903223-0A21D78A-9E43-4A20-AE20-9867FC16F58E

Q33903223-65B4B102-3064-4543-B03E-0F87BCF9F46A

Q33903223-6F4A32EF-3BC9-4C69-BD72-A4D58B15EBAA

Q33903223-7B3AD6A3-A88B-4957-A7A5-DDB8FCE358BF

Q33903223-8188204D-30D0-4F6A-A646-65AADFB5BD65

P2860

Q33903223-0061D0E6-9E73-4A70-BB17-15C982F8BAE9

Q33903223-01C19943-42A5-4110-AB78-0D1C5D9A81B8

Q33903223-027739FE-AA94-4FFC-9C4B-E7930F34D93A

Q33903223-03697D54-2417-4BF9-90AA-3504B85867E3

Q33903223-09C591B4-C673-433B-A9BF-1F5BA8F7BC8E

Q33903223-0A012BD4-1868-47D8-B140-F661CE5597CB

Q33903223-0AD8A148-E17B-4BB3-8827-1678AE53999F

Q33903223-0C5965D0-76FB-4FBE-8EBA-567A1B47990F

Q33903223-0D81CBBD-F951-4D30-BBD2-AF739923F29B

Q33903223-0FCC2028-24A0-47A0-B02E-14277EB235BB

P304

Q33903223-8A33257E-42B7-4CC2-ADD5-64972B83E451

P31

Q33903223-4DDA7B4E-46C8-47BC-A356-789705A25BA5

P356

Q33903223-626372C5-C93B-49D2-8687-878C0A915456

P433

Q33903223-1FAD5EA3-0007-45BA-84E8-B461A3CC07DB

P478

Q33903223-FD70C4A6-8BC2-4D68-BA35-94EA1F9E9214

P50

Q33903223-40215DF1-26B4-4E73-9EC3-8FDBF5C42B63

P577

Q33903223-460F8726-0687-4F3D-8CAF-3EDB09372609

P5875

Q33903223-5BB1BA88-D829-47BA-8643-7731D84935BA

P698

Q33903223-E68F7E8E-CD6F-42FA-8782-87E7060A86C4

P921

Q33903223-6AFDFF11-3E67-4577-B6BC-4918A63A1349

P932

Q33903223-6F090FF4-E9E7-4B28-9D05-B2CA44C0DB2F

P356

J.DRUP.2010.02.001

P1433

Drug Resistance Updates

P1476

Implication of microRNAs in drug resistance for designing novel cancer therapy

@en

P2093

Dejuan Kong

http://www.w3.org/2001/XMLSchema#string

Fazlul H Sarkar

http://www.w3.org/2001/XMLSchema#string

Shadan Ali

http://www.w3.org/2001/XMLSchema#string

Yiwei Li

http://www.w3.org/2001/XMLSchema#string

Zhiwei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice

The nuclear RNase III Drosha initiates microRNA processing

Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs

The Microprocessor complex mediates the genesis of microRNAs

The Drosha-DGCR8 complex in primary microRNA processing

MicroRNA maturation: stepwise processing and subcellular localization.

miR-15 and miR-16 induce apoptosis by targeting BCL2

Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing

MicroRNA genes are transcribed by RNA polymerase II

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes

P304

57-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUP.2010.02.001

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Fazlul H. Sarkar

P577

2010-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42254917

http://www.w3.org/2001/XMLSchema#string

P698

20236855

http://www.w3.org/2001/XMLSchema#string

P921

P932

2883024

http://www.w3.org/2001/XMLSchema#string